Clarius Group, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 215 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$108,600
-42.0%
10,0000.0%0.01%
-38.5%
Q1 2024$187,400
-13.5%
10,0000.0%0.01%
-27.8%
Q4 2023$216,700
-4.2%
10,000
-9.0%
0.02%
-18.2%
Q3 2023$226,257
-55.3%
10,994
+2.2%
0.02%
-43.6%
Q2 2023$505,653
+12.1%
10,7540.0%0.04%
+2.6%
Q1 2023$451,238
+109958.0%
10,7540.0%0.04%
+2.7%
Q4 2022$410
-99.9%
10,754
+0.3%
0.04%
-11.9%
Q3 2022$420,000
+27.7%
10,726
+5.4%
0.04%
+27.3%
Q2 2022$329,000
-84.8%
10,177
-71.3%
0.03%
-88.2%
Q3 2020$2,170,000
+47.0%
35,5000.0%0.28%
+34.8%
Q2 2020$1,476,000
+44.7%
35,5000.0%0.21%
+7.8%
Q1 2020$1,020,000
-61.6%
35,5000.0%0.19%
-54.4%
Q4 2019$2,659,000
-66.9%
35,500
-72.5%
0.42%
-87.6%
Q3 2017$8,041,000
-32.3%
129,068
-13.4%
3.38%
-30.8%
Q2 2017$11,872,000
+12.1%
149,0680.0%4.89%
+11.8%
Q1 2017$10,594,000
+33.9%
149,0680.0%4.38%
+30.8%
Q4 2016$7,911,000
+15.2%
149,0680.0%3.35%
+4.5%
Q3 2016$6,865,000
+52.9%
149,0680.0%3.20%
+33.7%
Q2 2016$4,491,000
+26.3%
149,068
+34.4%
2.39%
+21.4%
Q1 2016$3,557,000110,9501.97%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders